Bharat Rasayan DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.77×0.76×0.83×0.87×0.69×
1.21×1.10×1.14×1.20×1.05×
12.4%13.9%12.6%8.8%13.9%
0.87×0.87×0.90×0.92×1.14×
1.12×1.12×1.25×1.21×1.20×
11.4%11.5%13.5%10.2%13.8%
12.1%12.1%13.3%10.2%15.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BHARATRAS₹948.20

Bharat Rasayan Limited

· Chemicals
₹ CrorePeersINSECTICIDIPLMOLGSPCROPPUNJABCHEMASTECBHAGCHEMNACLINDMcap ₹1,576 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.690.870.830.760.77
Interest Burden (Pretax/EBIT) ×1.051.201.141.101.21
EBIT Margin %13.888.7612.6113.9112.45
Asset Turnover ×1.140.920.900.870.87
Financial Leverage (Assets/Equity) ×1.201.211.251.121.12
ROE (5-step product, year-end total equity) %13.8310.2013.4711.4711.37
ROE (owners' profit / average owners' equity) %14.9810.1513.3112.1212.12
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.